• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

VALNEVA (VLA)

VALNEVA SE
Sell: €3.70|Buy: €3.78|Change: 0.01 (-0.32%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generatefuture cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Address



FRA

Telephone

+33 022 8073710

Website

https://www.valneva.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Valneva SE Third Quarter Earnings Conference Call for 20262026-11-20T09:00:00
Valneva SE Third Quarter Earnings Results for 20262026-11-20T00:00:00
Valneva SE Second Quarter Earnings Results for 20262026-08-12T00:00:00
Valneva SE Second Quarter Earnings Conference Call for 20262026-08-12T00:00:00
Valneva SE Annual General Meeting for 20262026-06-25T00:00:00
Valneva SE First Quarter Earnings Results for 20262026-05-07T00:00:00
Valneva SE First Quarter Earnings Conference Call for 20262026-05-07T00:00:00
Valneva SE Annual Report for 20252026-03-24T00:00:00
Valneva SE Fourth Quarter Earnings Results for 20252026-03-20T00:00:00
Valneva SE Fourth Quarter Earnings Conference Call for 20252026-03-20T00:00:00

Previous key dates

NameKey Date
Valneva SE Third Quarter Earnings Conference Call for 20252025-11-20T09:00:00
Valneva SE Third Quarter Earnings Result for 20252025-11-20T00:00:00
Jefferies London Healthcare Conference2025-11-19T14:00:00
Valneva SE Stifel 2025 Healthcare Conference2025-11-11T09:20:00
Valneva SE Guggenheim 2 nd Annual Healthcare Innovation Conference2025-11-10T10:30:00
Valneva SE Second Quarter Earnings Result for 20252025-08-12T00:00:00
Valneva SE Second Quarter Earnings Conference Call for 20252025-08-12T00:00:00
Valneva SE Annual General Meeting for 20252025-06-25T00:00:00
Goldman Sachs 46 th Annual Global Healthcare Conference2025-06-09T13:20:00
Jefferies Global Healthcare Conference2025-06-05T11:40:00
Valneva SE First Quarter Earnings Result for 20252025-05-07T00:00:00
Valneva SE First Quarter Earnings Conference Call for 20252025-05-07T00:00:00
Valneva SE Annual Report for 20242025-03-24T00:00:00
Valneva SE Fourth Quarter Earnings Result for 20242025-03-20T00:00:00
Valneva SE Fourth Quarter Earnings Conference Call for 20242025-03-20T00:00:00
TD Cowen 45th Annual Health Care Conference2025-03-04T13:10:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.